Vivace Therapeutics (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Company Description
- Vivace Therapeutics is a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway.
- Market
- Cancer Therapies
- Location
- San Mateo, California, USA
- Coinvestors
- Canaan Partners, Cenova Capital